Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Associations Between Microbiota, Mitochondrial Function, and Cognition in Chronic Marijuana Users. ✅
Go to Publication ✅
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (J Neuroimmune Pharmacol ) Vol: 13 Issue 1 Pages: 113-122 Pub: 2018 Mar Epub: 2017 Nov 4 Authors Panee J , Gerschenson M , Chang L , |
|
|
Associations Between Microbiota, Mitochondrial Function, and Cognition in Chronic Marijuana Users. ✅
Go to Publication ✅
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology (J Neuroimmune Pharmacol ) Vol: 13 Issue 1 Pages: 113-122 Pub: 2018 Mar Epub: 2017 Nov 4 Authors Panee J , Gerschenson M , Chang L , |
|
|
Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract. ✅
Go to Publication ✅
Journal of dietary supplements (J Diet Suppl ) Vol: 17 Issue 5 Pages: 543-560 Pub: 2020 Epub: 2020 May 13 Authors Skinner CM , Nookaew I , Ewing LE , Wongsurawat T , Jenjaroenpun P , Quick CM , Yee EU , Piccolo BD , ElSohly M , Walker LA , Gurley B , Koturbash I , |
|
|
Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract. ✅
Go to Publication ✅
Journal of dietary supplements (J Diet Suppl ) Vol: 17 Issue 5 Pages: 543-560 Pub: 2020 Epub: 2020 May 13 Authors Skinner CM , Nookaew I , Ewing LE , Wongsurawat T , Jenjaroenpun P , Quick CM , Yee EU , Piccolo BD , ElSohly M , Walker LA , Gurley B , Koturbash I , |
|
|
Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract. ✅
Go to Publication ✅
Journal of dietary supplements (J Diet Suppl ) Vol: 17 Issue 5 Pages: 543-560 Pub: 2020 Epub: 2020 May 13 Authors Skinner CM , Nookaew I , Ewing LE , Wongsurawat T , Jenjaroenpun P , Quick CM , Yee EU , Piccolo BD , ElSohly M , Walker LA , Gurley B , Koturbash I , |
|
|
Potential Probiotic or Trigger of Gut Inflammation - The Janus-Faced Nature of Cannabidiol-Rich Cannabis Extract. ✅
Go to Publication ✅
Journal of dietary supplements (J Diet Suppl ) Vol: 17 Issue 5 Pages: 543-560 Pub: 2020 Epub: 2020 May 13 Authors Skinner CM , Nookaew I , Ewing LE , Wongsurawat T , Jenjaroenpun P , Quick CM , Yee EU , Piccolo BD , ElSohly M , Walker LA , Gurley B , Koturbash I , |
|
|
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. ✅
Go to Publication ✅
Brain, behavior, and immunity (Brain Behav Immun ) Vol: 82 Issue Pages: 25-35 Pub: 2019 Nov Epub: 2019 Jul 26 Authors Al-Ghezi ZZ , Busbee PB , Alghetaa H , Nagarkatti PS , Nagarkatti M , |
|
|
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. ✅
Go to Publication ✅
Brain, behavior, and immunity (Brain Behav Immun ) Vol: 82 Issue Pages: 25-35 Pub: 2019 Nov Epub: 2019 Jul 26 Authors Al-Ghezi ZZ , Busbee PB , Alghetaa H , Nagarkatti PS , Nagarkatti M , |
|
|
Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. ✅
Go to Publication ✅
Brain, behavior, and immunity (Brain Behav Immun ) Vol: 82 Issue Pages: 25-35 Pub: 2019 Nov Epub: 2019 Jul 26 Authors Al-Ghezi ZZ , Busbee PB , Alghetaa H , Nagarkatti PS , Nagarkatti M , |
|
|
Beneficial metabolic transformations and prebiotic potential of hemp bran and its alcalase hydrolysate, after colonic fermentation in a gut model. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 1552 Pub: 2023 Jan 27 Epub: 2023 Jan 27 Authors Nissen L , Casciano F , Babini E , Gianotti A , |
|
|
Beneficial metabolic transformations and prebiotic potential of hemp bran and its alcalase hydrolysate, after colonic fermentation in a gut model. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 13 Issue 1 Pages: 1552 Pub: 2023 Jan 27 Epub: 2023 Jan 27 Authors Nissen L , Casciano F , Babini E , Gianotti A , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Integrating fecal metabolomics and intestinal microbiota to study the mechanism of cannabidiol in the treatment of idiopathic pulmonary fibrosis. ✅
Go to Publication ✅
Frontiers in pharmacology (Front Pharmacol ) Vol: 15 Issue Pages: 1358626 Pub: 2024 Epub: 2024 Feb 6 Authors Sun M , Zhang F , Lu F , Yu D , Wang Y , Chen P , Liu S , |
|
|
Comparative Analysis of the Antimicrobial Activity of Essential Oils and Their Formulated Microemulsions against Foodborne Pathogens and Spoilage Bacteria. ✅
Go to Publication ✅
Antibiotics (Basel, Switzerland) (Antibiotics (Basel) ) Vol: 11 Issue 4 Pages: Pub: 2022 Mar 25 Epub: 2022 Mar 25 Authors Campana R , Tiboni M , Maggi F , Cappellacci L , Cianfaglione K , Morshedloo MR , Frangipani E , Casettari L , |
|
|
The Potential Antinociceptive Effect and Mechanism of Cannabis sativa L. Extract on Paclitaxel-Induced Neuropathic Pain in Rats Uncovered by Multi-Omics Analysis. ✅
Go to Publication ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 29 Issue 9 Pages: Pub: 2024 Apr 25 Epub: 2024 Apr 25 Authors Xu Y , Yao L , Guo Y , Shi C , Zhou J , Hua M , |
|
|
The Potential Antinociceptive Effect and Mechanism of Cannabis sativa L. Extract on Paclitaxel-Induced Neuropathic Pain in Rats Uncovered by Multi-Omics Analysis. ✅
Go to Publication ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 29 Issue 9 Pages: Pub: 2024 Apr 25 Epub: 2024 Apr 25 Authors Xu Y , Yao L , Guo Y , Shi C , Zhou J , Hua M , |
|
|
Cannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System. ✅
Go to Publication ✅
Journal of clinical medicine (J Clin Med ) Vol: 12 Issue 22 Pages: Pub: 2023 Nov 13 Epub: 2023 Nov 13 Authors Farooqi T , Bhuyan DJ , Low M , Sinclair J , Leonardi M , Armour M , |
|
|
Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 13 Issue Pages: 882455 Pub: 2022 Epub: 2022 Sep 26 Authors Ben Necib R , Manca C , Lacroix S , Martin C , Flamand N , Di Marzo V , Silvestri C , |
|
|
Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 13 Issue Pages: 882455 Pub: 2022 Epub: 2022 Sep 26 Authors Ben Necib R , Manca C , Lacroix S , Martin C , Flamand N , Di Marzo V , Silvestri C , |
|
|
Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 13 Issue Pages: 882455 Pub: 2022 Epub: 2022 Sep 26 Authors Ben Necib R , Manca C , Lacroix S , Martin C , Flamand N , Di Marzo V , Silvestri C , |
|
|
Cannabidiol improves the cognitive function of SAMP8 AD model mice involving the microbiota-gut-brain axis. ✅
Go to Publication ✅
Journal of toxicology and environmental health. Part A (J Toxicol Environ Health A ) Vol: 87 Issue 11 Pages: 471-479 Pub: 2024 Jun 2 Epub: 2024 Apr 9 Authors Ma BQ , Jia JX , Wang H , Li SJ , Yang ZJ , Wang XX , Yan XS , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
